NCT03794908View on ClinicalTrials.gov

Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

July 15, 2021

Study Completion Date

July 15, 2021

Conditions
FibromyalgiaFMS
Interventions
DEVICE

Light therapy A (Bright) via the Re-Timer®

Subjects will conduct light treatment in the mornings at home for one hour using Re-timer®.

DEVICE

Light therapy B (Dim) via the Re-Timer®

Subjects will conduct light treatment in the mornings at home for one hour using Re-timer®.

Trial Locations (1)

48109

The University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

lead

University of Michigan

OTHER

NCT03794908 - Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome | Biotech Hunter | Biotech Hunter